Biliary pseudolithiasis

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 125.239.115.8 (talk) at 14:03, 21 June 2016. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Mass-like sludge in common bile duct (A) and the gallbladder (B) in a neonate who received ceftriaxone

Biliary pseudolithiasis refers to an unusual complication of ceftriaxone where the drug complexes with calcium and mimics gallstones.[1][2] It is reversed when ceftriaxone administration is stopped.[2] It was first described in 1988 by Schaad et al. as "reversible ceftriaxone-associated biliary pseudolithiasis".[2]

See also

References

  1. ^ Kirejczyk, W. M.; Crowe, H. M.; MacKay, I. M.; Quintiliani, R; Cronin, E. B. (1992). "Disappearing "gallstones": Biliary pseudolithiasis complicating ceftriaxone therapy". American Journal of Roentgenology. 159 (2): 329–30. doi:10.2214/ajr.159.2.1632349. PMID 1632349.
  2. ^ a b c Schaad, U. B.; Wedgwood-Krucko, J; Tschaeppeler, H (1988). "Reversible ceftriaxone-associated biliary pseudolithiasis in children". Lancet. 2 (8625): 1411–3. doi:10.1016/s0140-6736(88)90596-x. PMID 2904533.